MALAT1 and diabetic kidney disease: In the DKD context, some studies have also reported thatalterations in MALAT1 expression were associated with cellviability, apoptosis, inflammatory response, and cell injury pathways (Song et al., 2022; Yang et al., 2022; Shoeib etal., 2023).